SCHEMBL25818423

SCHEMBL25818423

Clc1nc(-c2cccc(-c3ccc4ccc(-c5ccccc5)cc4c3)c2)nc(-c2ccc3c(c2)sc2ccccc23)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
LIMK1 P53667 2/20 0.36
PIK3CA P42336 1/20 0.35
PI4KA P42356 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
MCL1 Q07820 1/20 0.35
GPR3 P46089 1/20 0.34
F9 P00740 2/20 0.33
NR1I3 Q14994 1/20 0.33
PIM3 Q86V86 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
RPA1 P27694 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818432 0.96 ALDH1A1 (0.37) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL25818448 0.96 ESR1 (0.39) ALDH1A1HPGDSMN1; SMN2MAPTESR1
SCHEMBL25818453 0.95 ALDH1A1 (0.36) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL25706239 0.95 ALDH1A1 (0.40) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL22161420 0.94 ALDH1A1 (0.39) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL25818535 0.93 LIMK1 (0.33) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL25818528 0.93 PIM3 (0.38) ALDH1A1HPGDSMN1; SMN2ESR1ESR2
SCHEMBL23437788 0.92 ALDH1A1 (0.40) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL25818529 0.92 ALDH1A1 (0.34) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL25817720 0.91 ESR1 (0.39) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 ALDH1A1 1010/4885HPGD 2663/4885SMN1; SMN2 474/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 ALDH1A1 1010/4885HPGD 2663/4885SMN1; SMN2 474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.